Medical technology company Cairn Surgical has submitted a De Novo 510(k) application to the U.S. Food and Drug Administration (FDA) seeking clearance for the Breast Cancer Locator (BCL) System, a patient-specific 3D printed device designed to improve tumor localization during breast conserving surgery. Clinical data included in the submission shows negative margins achieved in 94% […]
Monday, March 23, 2026
Cairn Surgical’s 3D Printed Breast Cancer Locator Heads to FDA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment